Rachelle Seguin

Driven by a desire to explore the mind-skin connection, Rachelle Seguin sheds light on how stress, emotions, and hormones impact skin health. A chemist with a Master’s in Pharmaceutical Sciences, her research focused on the effects of stress hormones on psoriasis using tissue engineering techniques.

As the co-founder and president of Omy Laboratories, a certified B-Corp, Rachelle has revolutionized dermocosmetics with AI-powered personalized skincare. Her work integrates neurocosmetic ingredients that interact with the skin’s sensory system, enhancing the connection between science and well-being.

Under her leadership, Omy has reached over 200,000 customers across North America with high-performance, dermatologist-tested products designed for sensitive skin. The award-winning company has earned over 50 distinctions for innovation, quality, and environmental commitment while raising $11M in 2022 to expand internationally.

Recognized as a Forbes 30 Under 30 honoree, Rachelle bridges science and entrepreneurship to transform how people care for their skin.